Cargando…
Microglia as a cellular target of diclofenac therapy in Alzheimer’s disease
Alzheimer’s disease (AD) is an untreatable cause of dementia, and new therapeutic approaches are urgently needed. AD pathology is defined by extracellular amyloid plaques and intracellular neurofibrillary tangles. Research of the past decades has suggested that neuroinflammation plays a critical rol...
Autores principales: | Stopschinski, Barbara E., Weideman, Rick A., McMahan, Danni, Jacob, David A., Little, Bertis B., Chiang, Hsueh-Sheng, Saez Calveras, Nil, Stuve, Olaf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974624/ https://www.ncbi.nlm.nih.gov/pubmed/36875711 http://dx.doi.org/10.1177/17562864231156674 |
Ejemplares similares
-
Diclofenac reduces the risk of Alzheimer’s disease: a pilot analysis of NSAIDs in two US veteran populations
por: Stuve, Olaf, et al.
Publicado: (2020) -
The role of the complement system in Multiple Sclerosis: A review
por: Saez-Calveras, Nil, et al.
Publicado: (2022) -
The validity of animal models to explore the pathogenic role of the complement system in multiple sclerosis: A review
por: Saez-Calveras, Nil, et al.
Publicado: (2022) -
Cognitive Decline in Older People with Multiple Sclerosis—A Narrative Review of the Literature
por: Chiang, Hsueh-Sheng, et al.
Publicado: (2022) -
Limb myorhythmia treated with chemodenervation: a case report
por: Saez-Calveras, Nil, et al.
Publicado: (2023)